Abstract
Breast cancer is increasing at an alarming rate in women around the world, where medical biology is confronted by this disease on two crucial fronts. The first step is the early accurate diagnosis, which is very critical and the second step involves the appropriate clinical management. The current trend in molecular imaging of breast cancer provides not only an excellent tool in diagnosing the disease but also useful in validating the potentiality of pharmaceutical interventions. This review addresses the effectiveness of targeted imaging technologies to resolve the molecular characterisation and pathological evidences in breast cancer. The focus is on the present practices in breast cancer imaging, specifically targeting cellular machineries such as hormone receptors and angiogenic factors.
Keywords: Molecular imaging, breast cancer, hormones, estrogen receptor, molecular therapy, estradiol, early accurate diagnosis, appropriate clinical management, pharmaceutical interventions, cellular machineries, angiogenic factors, availability of screening tools, of screening tools, adjuvant therapy, Hormonal therapy
Current Pharmaceutical Biotechnology
Title: Molecular Targeting of Breast Cancer: Molecular Imaging and Therapy
Volume: 12 Issue: 4
Author(s): Parasuraman Padmanabhan, Julian Goggi, Romain Bejot and Kishore K. Bhakoo
Affiliation:
Keywords: Molecular imaging, breast cancer, hormones, estrogen receptor, molecular therapy, estradiol, early accurate diagnosis, appropriate clinical management, pharmaceutical interventions, cellular machineries, angiogenic factors, availability of screening tools, of screening tools, adjuvant therapy, Hormonal therapy
Abstract: Breast cancer is increasing at an alarming rate in women around the world, where medical biology is confronted by this disease on two crucial fronts. The first step is the early accurate diagnosis, which is very critical and the second step involves the appropriate clinical management. The current trend in molecular imaging of breast cancer provides not only an excellent tool in diagnosing the disease but also useful in validating the potentiality of pharmaceutical interventions. This review addresses the effectiveness of targeted imaging technologies to resolve the molecular characterisation and pathological evidences in breast cancer. The focus is on the present practices in breast cancer imaging, specifically targeting cellular machineries such as hormone receptors and angiogenic factors.
Export Options
About this article
Cite this article as:
Padmanabhan Parasuraman, Goggi Julian, Bejot Romain and K. Bhakoo Kishore, Molecular Targeting of Breast Cancer: Molecular Imaging and Therapy, Current Pharmaceutical Biotechnology 2011; 12 (4) . https://dx.doi.org/10.2174/138920111795163959
DOI https://dx.doi.org/10.2174/138920111795163959 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Electric cable: cytoskeleton as an electric transmitter for cancer therapy
Current Signal Transduction Therapy Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes
Anti-Cancer Agents in Medicinal Chemistry Antidiabetic Potential of Fabaceae Family: An Overview
Current Nutrition & Food Science Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
Anti-Cancer Agents in Medicinal Chemistry Role of Epigenetics and Oxidative Stress in Gliomagenesis
CNS & Neurological Disorders - Drug Targets Profilin 1 Potentiates Apoptosis Induced by Staurosporine in Cancer Cells
Current Molecular Medicine An efficient Synthesis of New Fused Oxazinocarbazoles
Letters in Organic Chemistry Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update
Current Drug Targets An Approach Towards the Quantitative Structure-Activity Relationships for Sulfamate-Based Estrone Sulfatase Inhibitors
Letters in Drug Design & Discovery Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer
Recent Patents on Nanotechnology A Three-gene-based Type 1 Diabetes Diagnostic Signature
Current Pharmaceutical Design Synthesis and in vitro Anti-tumor Activity of Some New Sebacoyl Chloride Based Heterocycles
Current Organic Synthesis Cancer Stem Cell Model in Oral Squamous Cell Carcinoma
Current Stem Cell Research & Therapy TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design Ligand-receptor Engineering and its Application Towards the Complementation of Genetic Disease and Target Identification
Current Topics in Medicinal Chemistry Translational Multimodality Neuroimaging
Current Drug Targets Smart Inulin-Based Polycationic Nanodevices for siRNA Delivery
Current Drug Delivery The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Tumor Physiology and Charge Dynamics of Anticancer Drugs: Implications for Camptothecin-based Drug Development
Current Medicinal Chemistry